top of page


INTEGRATING SCIENCE
& THERAPEUTICS
RESEARCH AT FAKNOSTICS LLC IS FOCUSED ON DEVELOPMENT OF BOTH DIAGNOSTICS AND THERAPEUTICS AROUND THE MAJOR CANCER PROTEIN FOCAL ADHESION KINASE (FAK)
PUBLICATIONS
We have been publishing research on FAK since 1993
See our entire list of academic publications.
.png)
CANCER
FAK is considered to be an especially promising cancer drug target for solid tumors.
We have developed an effective inhibitor that targets the kinase independent FAT domain of FAK with efficacy at nanomolar dosage.

PLASTIC SURGERY
We are currently testing the effectiveness and dosing of our FAK inhibitor for the reduction of skin fibrosis with a view towards plastic surgery applications

FIBROSIS
FAK over-expression is associated with fibrosis induced by biochemical stress.
We are developing our proprietary FAK inhibitor to target liver fibrosis induced by NAFLD, alcoholism and infectious diseases.

bottom of page